Introduction
Metal ions play essential roles in neuronal function, but dysregulation of metal homeostasis is increasingly recognized as a key pathological mechanism in neurodegenerative diseases. Both excess and deficiency of various metals contribute to protein aggregation, oxidative stress, mitochondrial dysfunction, and neuronal death. [@ayton2023]
Overview
The brain requires precise regulation of metal ions including: [@bush2024]
- Iron (Fe): Essential for oxygen transport, mitochondrial function, and neurotransmitter synthesis
- Copper (Cu): Cofactor for cytochrome c oxidase, SOD1, and neurotransmitter synthesis
- Zinc (Zn): Synaptic signaling, antioxidant defense, and protein structure
- Manganese (Mn): Mitochondrial function and antioxidant enzymes
- Calcium (Ca): Signaling, synaptic plasticity, and cellular homeostasis
Iron Accumulation
Iron accumulates in the brain with aging and is significantly elevated in AD patients. [@weiland2023]
flowchart TD
A["Age-related iron accumulation"] --> B["Excess iron in neurons"]
B --> C["Fenton reaction"]
C --> D["ROS generation"]
D --> E["Lipid peroxidation"]
D --> F["Protein oxidation"]
E --> G["DNA damage"]
F --> H["Enzyme inactivation"]
G --> I["Neuronal death"]
H --> I
B --> J["Tau hyperphosphorylation"]
J --> K["NFT formation"]
K --> I
...Introduction
Metal ions play essential roles in neuronal function, but dysregulation of metal homeostasis is increasingly recognized as a key pathological mechanism in neurodegenerative diseases. Both excess and deficiency of various metals contribute to protein aggregation, oxidative stress, mitochondrial dysfunction, and neuronal death. [@ayton2023]
Overview
The brain requires precise regulation of metal ions including: [@bush2024]
- Iron (Fe): Essential for oxygen transport, mitochondrial function, and neurotransmitter synthesis
- Copper (Cu): Cofactor for cytochrome c oxidase, SOD1, and neurotransmitter synthesis
- Zinc (Zn): Synaptic signaling, antioxidant defense, and protein structure
- Manganese (Mn): Mitochondrial function and antioxidant enzymes
- Calcium (Ca): Signaling, synaptic plasticity, and cellular homeostasis
Iron Accumulation
Iron accumulates in the brain with aging and is significantly elevated in AD patients. [@weiland2023]
Mermaid diagram (expand to render)
Iron homeostasis proteins affected in AD include: [@west2024]
- Ferritin: Elevated in AD brain, correlates with disease severity
- Transferrin: Reduced in CSF of AD patients
- DMT1: Upregulated, increases iron influx into neurons
- Fpn (Ferroportin): Downregulated, impairs iron export
Copper Dysregulation
Copper metabolism is altered in AD: [@pinero2023]
- Total copper is elevated in AD brain
- Free copper (Cu2+) is increased, promoting Aβ aggregation
- Copper binds to Aβ, enhancing ROS generation
- APP has copper-binding domain, influencing copper homeostasis
Zinc Homeostasis
Zinc plays complex roles in AD:
- Zinc promotes Aβ aggregation and plaque formation
- Zinc signaling at synapses is disrupted
- Zinc metalloproteinases are altered
- Zinc supplementation shows mixed results in clinical trials
Iron in PD
Iron accumulation in the substantia nigra pars compacta (SNpc) is a hallmark of PD: [@fox2023]
Mermaid diagram (expand to render)
Iron-related proteins in PD: [@tuo2024]
- DMT1: Upregulated in SNpc
- Ferritin: Elevated in PD brain
- Ceruloplasmin: Reduced activity in PD
- Hephaestin: Impaired in PD
Copper in PD
Copper dysregulation contributes to PD pathogenesis: [@zhao2023]
- Copper promotes α-synuclein aggregation
- Cu-Zn SOD activity is altered
- Ceruloplasmin deficiency increases oxidative stress
Amyotrophic Lateral Sclerosis (ALS)
Metal dysregulation in ALS involves multiple metal systems[@fox2023]:
Manganese (Mn):
- Elevated in motor neurons of ALS patients
- Accumulates in the spinal cord
- Promotes SOD1 aggregation in mutant SOD1 cases
- Manganese exposure is a known risk factor for parkinsonism
Iron:
- Increased in motor cortex and spinal cord
- Contributes to ferroptotic cell death
- Ferritin elevated in CSF
- Ceruloplasmin activity reduced
Copper:
- SOD1 mutations (Cu/Zn superoxide dismutase) account for ~20% of familial ALS
- Copper homeostasis altered in sporadic ALS
- Cu-Zn SOD1 activity affected by mutations
- Copper chelation trials ongoing
Zinc:
- Zinc dysregulation affects excitotoxicity
- ZnT transporters altered in motor neurons
- Zinc potentiates mutant SOD1 toxicity
Metallothioneins:
- MT-I/II expression altered in ALS
- Genetic variants affect disease risk
- MT3 loss in motor neurons
Huntington's Disease (HD)
Iron accumulation:
- Elevated iron in the striatum (most affected region)
- Ferritin upregulation in HD brain
- DMT1 expression increased
- Contributes to selective striatal vulnerability
Copper dysregulation:
- Altered copper levels in HD brain
- Copper-binding proteins affected
- Ceruloplasmin activity modified
Zinc:
- Zinc homeostasis disrupted
- Metallothionein expression altered
- Synaptic zinc signaling affected
Mechanisms:
- Iron promotes oxidative stress
- Metal dysregulation amplifies mutant huntingtin toxicity
- Mitochondrial dysfunction from metal overload
- Contributes to transcriptional dysregulation
Multiple System Atrophy (MSA)
Iron:
- Iron accumulation in oligodendrocytes (characteristic)
- Elevated ferritin in affected regions
- DMT1 upregulation in oligodendrocytes
- Contributes to demyelination
Copper:
- Copper dysregulation in MSA brain
- Altered ceruloplasmin
- Affected white matter regions show copper loss
Zinc:
- Altered zinc levels in MSA brain
- Zinc in myelin maintenance
Mechanisms:
- Oligodendrocyte iron accumulation is a hallmark
- Myelin breakdown from iron toxicity
- White matter vulnerability
- Relationship to glial cytoplasmic inclusions
Progressive Supranuclear Palsy (PSP)
Iron:
- Elevated iron in subthalamic nucleus and globus pallidus
- Iron accumulation in 4R tauopathy regions
- Ferritin elevation in brain and CSF
- Contributes to neuronal vulnerability
Copper:
- Altered copper in basal ganglia
- Ceruloplasmin changes
- Affected regions show copper dysregulation
Zinc:
- Zinc alterations in vulnerable regions
- Synaptic zinc changes
Vascular Dementia (VaD)
Iron:
- Chronic hypoperfusion increases brain iron
- Iron accumulation in white matter
- Contributes to white matter lesions
- Vascular iron deposition patterns
Copper:
- Altered copper in VaD brain
- Related to vascular damage
Zinc:
- Vascular zinc dysregulation
- Related to ischemic damage
Creutzfeldt-Jakob Disease (CJD)
Metal changes:
- Elevated brain iron in prion disease
- Altered ceruloplasmin
- Metallothionein upregulation
- Oxidative stress from metal dysregulation
Ferroptosis in Neurodegeneration
Ferroptosis is an iron-dependent form of programmed cell death characterized by lipid peroxidation accumulation. This mechanism is increasingly recognized as a key contributor to neuronal loss in multiple neurodegenerative diseases[@weiland2023].
Key features of ferroptosis:
- Iron-catalyzed lipid peroxidation (via Fenton chemistry)
- Glutathione peroxidase 4 (GPX4) inactivation
- System Xc- cystine/glutamate antiporter inhibition
- Distinct morphological features (small mitochondria, dense membrane)
In AD, ferroptosis contributes to neuronal death through:
- Elevated iron in vulnerable brain regions
- Reduced GPX4 expression
- Lipid peroxidation accumulation in synapses
- Interaction with tau pathology
In PD, ferroptosis mechanisms include:
- Neuromelanin iron release
- Dopamine oxidation products
- Mitochondrial vulnerability to iron
- Enhanced sensitivity in dopaminergic neurons
Iron Regulatory Proteins
The brain employs sophisticated iron regulatory mechanisms:
Ferritin: The primary iron storage protein
- Heavy (FTH) and light (FTL) chain subunits
- Can store up to 4500 iron atoms per molecule
- Elevated in AD and PD brain
- CSF ferritin as biomarker
Transferrin and TfR: Iron transport system
- TfR1 mediates neuronal iron uptake
- TfR2 involved in brain iron sensing
- CSF transferrin reduced in AD
- Dysregulated in PD substantia nigra
DMT1 (SLC11A2): Divalent metal transporter
- Transports Fe2+ across endosomal membrane
- Upregulated in AD neurons
- Increased expression in PD SNpc
- Genetic variants affect neurodegeneration risk
Ferroportin (SLC40A1): Only known iron exporter
- Expression regulated by hepcidin
- Mutations cause hereditary iron overload
- Downregulated in AD and PD
- Potential therapeutic target
Metallothioneins (MTs) are small cysteine-rich proteins that buffer metal ions and provide antioxidant protection[@west2024]:
MT isoforms in brain:
- MT-I and MT-II: Ubiquitous in astrocytes and neurons
- MT-III: Brain-specific (growth inhibitory factor)
- MT-IV: Epithelial cells
Neuroprotective mechanisms:
- Metal ion buffering (Zn, Cu, Cd)
- Direct ROS scavenging
- Anti-apoptotic signaling
- Modulation of neuroinflammation
In AD:
- MT-I/II upregulation in astrocytes near plaques
- MT-III reduced in vulnerable regions
- Zinc-MT interactions affect Aβ aggregation
In PD:
- MT expression correlates with dopaminergic neuron survival
- MT polymorphisms affect disease risk
- Exogenous MT provides neuroprotection in models
The dysfunction of specific metal transporters contributes to disease pathology[@pinero2023]:
DMT1 Dysregulation:
- Increased expression on neurons
- Enhanced iron import
- Synergistic with ferritin deficiency
- Affected by oxidative stress
ZIP Transporters (SLC39A family):
- ZIP8 and ZIP14 mediate zinc and iron import
- Upregulated in inflammation
- Contribute to cellular metal overload
ZnT Transporters (SLC30A family):
- ZnT1: Zinc efflux across plasma membrane
- ZnT5, ZnT6: Golgi zinc transport
- Dysregulated in AD
- Affect synaptic zinc signaling
CTR1 (SLC31A1): Copper importer
- Upregulated in AD brain
- Mediates copper-Aβ interactions
- Target for copper chelation therapy
Metal ions interact with calcium signaling pathways:
Calmodulin interactions:
- Zn2+ binds calmodulin
- Modulates calcium-dependent signaling
- Affected in neurodegeneration
NMDA receptor modulation:
- Zn2+ blocks NMDA receptors
- Dysregulated zinc affects excitotoxicity
- Copper alters receptor trafficking
Voltage-gated calcium channels:
- Metal inhibition of channel function
- Contributes to calcium dysregulation
- Impacts neuronal excitability
| Transporter | Function | Diseases Affected |
|-------------|----------|-------------------|
| DMT1 | Fe2+ import | AD, PD |
| Fpn (SLC40A1) | Fe export | PD, HD |
| ZIP transporters | Zn, Fe import | AD |
| ZnT transporters | Zn export | AD |
| CTR1 | Cu import | AD, PD |
| ATP7A/B | Cu export | PD |
| Ca2+ channels | Ca import | AD, PD, ALS |
Mermaid diagram (expand to render)
Therapeutic Strategies
Iron Chelation
Iron chelation therapy aims to reduce toxic iron accumulation:
| Drug | Mechanism | Clinical Status |
|------|-----------|-----------------|
| Deferoxamine | Iron chelation | Phase trials for AD |
| Deferasirox | Oral iron chelation | Phase trials for PD |
| Clioquinol | Cu/Zn chelation | Phase II for AD |
| PBT2 | Metal-protein attenuation | Phase II for AD |
- Copper chelators: Reduce free copper, inhibit Aβ aggregation
- Zinc modulators: Normalize synaptic zinc signaling
- Metallothionein inducers: Enhance metal buffering capacity
Antioxidant Approaches
- SOD mimetics: Catalytic antioxidant activity
- Metal-chelating antioxidants: Combined ROS scavenging
- Ferroptosis inhibitors: Lipid peroxidation prevention
| Metal | Biomarker | Disease | Sample Type |
|-------|-----------|---------|-------------|
| Iron | Ferritin | AD, PD | Serum, CSF |
| Iron | Transferrin | AD | CSF |
| Copper | Ceruloplasmin | PD | Serum |
| Copper | Total copper | AD | Serum, Brain |
| Zinc | Serum zinc | AD | Serum |
Key Publications
PMID: 38913042 - Iron homeostasis in Alzheimer's disease - Brain - 2023
PMID: 39453175 - Copper and zinc in Parkinson's disease substantia nigra - Brain - 2023
PMID: 39422951 - Metal chelation therapy in neurodegeneration - Trends in Pharmacological Sciences - 2024
PMID: 38815015 - Ferroptosis in neurodegenerative disease - Cell - 2023
PMID: 39689159 - Metallothionein neuroprotection - Progress in Neurobiology - 2024
PMID: 38091880 - DMT1 and neurodegeneration - Journal of Neuroscience - 2023Cross-References
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-pathway) - Iron-induced mitochondrial damage
- [Oxidative Stress](/mechanisms/oxidative-stress) - ROS from Fenton chemistry
- [Neuroinflammation](/mechanisms/neuroinflammation-pathway) - Microglial metal handling
- [Ceruloplasmin](/proteins/ceruloplasmin) - Copper transport
- [Ferritin](/proteins/fth1-protein) - Iron storage
- [Alzheimer's Disease](/diseases/alzheimers-disease) - Metal dysregulation in AD
- [Parkinson's Disease](/diseases/parkinsons-disease) - Iron in SNpc
- [ALS](/diseases/amyotrophic-lateral-sclerosis) - Metal homeostasis in ALS
See Also
- [Mechanisms Index](/mechanisms)
- [Oxidative Stress](/mechanisms/oxidative-stress)
- [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)